Variants of the hepatitis C virus in different risk groups. Comparative study of one genotyping and one serotyping method;Variantes del virus de la hepatitis C en diferentes grupos de riesgo. Estudio comparativo de un metodo de genotipificacion y otro de serotipificacion

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue 3, 1998, Pages 111-117

  Alonso, Pedro ^a   Orduña, Antonio ^b   San Miguel, Ángel ^a   Gutiérrez, María Purificatión ^b   Lorenzo, Belén ^b   Eiros, José María ^b   Bratos, Miguel Ángel ^b   Cuervo, Milagros ^b   Torres, Antonio Rodríguez ^b  

^a Hospital Comarcal de Monforte   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Epidemiology; Genotype; Hepatitis C virus; Serotype

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN;

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROTYPING; SPAIN; VIRUS TYPING;

BLOOD TRANSFUSION; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEROTYPING; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0031966724     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Kubo Y, Takeuchi K, Boonmar S, Katayama T, Choo QL, Kuo G et al. A cDNA fragment of hepatitis C virus isolated from an implicated donor of posttransfusion non-A, non-B hepatitis in Japan. Nucleic Acid Res 1989; 17: 10.367-10.372.
3. Takeuchi K, Boonmar S, Kubo Y, Katayama T, Harada H, Ohbayashi A et al. Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in postransfusion non-A, non-B hepatitis. Gene 1990; 91: 287-291.
4. Takeuchi K, Kubo Y, Boonmar S, Watanabe Y, Katayama T, Choo QL et al. Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleic Acids Res 1990; 18: 4.626.
5. Takada N, Takase S, Takada A, Takayasu D. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17: 277-283.
6. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-679.
7. Driesel G, Wirth D, Stork K, Baungorten R, Sucker U, Schreier E. Hepatitis C virus (NCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol 1994; 139: 379-388.
8. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13-18.
9. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14:35-40.
10. Kanoi K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1.543.
11. Cha TA, Beall E, Irvina B, Kolberg J, Chien D, Kuo G et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992;89: 7.144-7.148.
12. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-388.
13. Hawkins A, Davidson I, Simmonds P. Comparison of plasma virus load among individuals infected with hepatitis C virus (HCV) genotipes 1,2 and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay and in-house limitig dilution method. J Clin Microbiol 1997; 35: 187-192.
14. McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RF et al. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
15. Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T et al. Genotype dependence of hepatitis C virus antibodies detectable by the first generation enzyme-linked immunosorbent assay with c100-3 protein. J Clin Invest 1993; 92: 1.529-1.533.
16. Stuyver L, Van Arnhem W, Wyseur A, DeLeys R, Maertens G. Analysis of the putative E1 envelope and NS4a epitope regions of HCV type 3. Biochem Biophys Res Commun 1993; 192: 635-641.
17. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC et al. Mapping of serotype-specific immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993; 31: 1.493-1.503.
18. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborgh B, Van Heuverswyn et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1.093-1.102.
19. McOmish F, Yap PL, Dow BC, Follet EAC, Saleed AA, Simmonds P. Geographical distribution of hepatitis C virus genotypes in blood donors-an international collaborative survey. J Clin Microbiol 1994; 32: 884-892.
20. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, Zayadi AR et al. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1,2,3,4,5 and 6. J Gen Virol 1995; 76: 1.737-1.748.
21. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahone Y et al. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 1992; 16: 886-891.
22. Leon P, López JA, Elola C, Quan S, Echevarria JM. Typing of hepatitis C virus antibody with specific peptides in seropositive blood donors and comparison with genotyping of viral RNA. Vox Sang 1997; 72: 71-75.
23. Tsukiyama-kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M et al. Antigenicities of group I and II hepatitis C polypeptides. Molecular basis of diagnosis. Virology 1993; 192: 430-437.
24. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1.321-1.324.
25. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected Worldwide. Proc Natl Acad Sci USA 1993; 90: 8.234-8.238.
26. Davidson F, Simmonds P, Fergurson JC, Jarvis LM, Dow BC, Follet EAC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995; 76: 1.197-1.204.
27. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylo-genetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2.391-2.399.
28. Murphy D, Willens B, Delage G. Use of the 5' non-coding region for genoyping hepatitis C virus. J Infect Dis 1994; 169: 473-475.
29. Nousbaum JB, Pol S, Nalpas B, Laudais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative study group. Ann Intern Med 1995; 122: 161-168.
30. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyvert L, Duval J et al. Relantioship between hepatitis C virus genotyping and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1.607-1.610.
31. Andonov A, Chaudhary RK. Genotyping of Canadian hepatitis C virus isolates by PCR. J Clin Microbiol 1994; 32: 2.031-2.034.
32. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281-289.
33. Shev S, Widell A, Foberg U, Fryden A, Hermodsson S, Lindh G et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995; 23: 253-257.
34. Camps J, Estebán R. Hepatitis C. Enferm Infecc Microbiol Clin 1995; 13 (Supl): 31-39.
35. Forns X, Maluenda MD, López-Labrador FX, Ampurdanés S, Olmedo E, Costa J et al. Comparative study of three methods for genotyping hepatitis C virus strains in samples from spanish patients. J Clin Microbiol 1996; 34: 2.516-2.521.
36. Echevarría J, León P. Aspectos actuales del diagnóstico de la hepatitis C. Enferm Infecc Microbiol Clin 1995; 13: 387-389.
37. Gianini C, Thiers V, Nousbaum JB, Stuyver L, Maertens G, Bréchot C. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol 1995; 23: 246-253.
38. Ravaggi A, Rossini A, Mazza C, Puoti M, Marin MG, Cariani E. Hepatitis C virus genotypes in Northern Italy: Clinical and virological features. J Clin Microbiol 1996; 34: 2.922-2.925.
39. Bravo R, Soriano V, Garcia-Samaniego J, Gonzalez J, Castro A, Colmenero M et al. Hepatitis C virus genotypes in different risk population in Spain. J Infect Dis 1996; 183: 509-510.
40. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G et al. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661-668.
41. Tokita H, Man Shrestha S, Okamoto H, Sakamoto M, Horikita M, Iizuka H et al. Hepatitis C variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994; 75: 931-936.
42. Zhang ZX, Housson BG, Widell A, Nordeufelt E. Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reactions. APMIS 1992; 100: 851-855.
43. Baath L, Widell A, Nordeufelt E. A comparison between one first generation and three second generation anti-HCV ELISA: an investigation in high and low risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Virol Methods 1992; 40: 287-296.
44. Kanoi K, Kako M, Okamoto H. HCV genotypes inchronic hepatitis C and response to Interferon. Lancet 1992; 339: 1.543.
45. Yoshioka K, Kakumo S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: relatioship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299.
46. Jarvis LM, Watson HG, McOmish F, Pentherer JF, Ludlam CA, Simmonds P. HCV genotype variation in haemophiliacs. J Infect Dis 1994; 170: 1.018-1.022.
47. Dixit V, Quan S, Martin P, Larson D, Brezina M, Dinello R et al. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol 1995; 33: 2.978-2.983.
48. Marsden HS, Owsiancka AM, Graham S, Robertson CA, McLean GW, Subak-Sharpe JH. Advantages of branched peptides in serodiagnosis: detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity. J Immunol Methods 1992; 147: 65-72.